相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Purinergic receptors: new targets for the treatment of gout and fibrosis
Thomas Gicquel et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production
Xin Yu et al.
JOURNAL OF HEPATOLOGY (2017)
Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation
Shuang Jiang et al.
PHARMACOLOGICAL RESEARCH (2017)
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Daniel Cabrera et al.
SCIENTIFIC REPORTS (2017)
Liver X receptors agonists suppress NLRP3 inflammasome activation
Shui-Xing Yu et al.
CYTOKINE (2017)
被撤回的出版物: The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism (Retracted article. See vol. 293, pg. 20011, 2018)
Steven McRae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Innate Immune Cell Trafficking and Function During Sterile Inflammation of the Liver
Braedon McDonald et al.
GASTROENTEROLOGY (2016)
Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice
M. C. Morrison et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor
Ai Hua Zhang et al.
ORGANIC LETTERS (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients
Azadeh Askari et al.
VIRAL IMMUNOLOGY (2016)
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
Gabsik Yang et al.
SCIENTIFIC REPORTS (2016)
Hepatitis regulation by the inflammasome signaling pathway
Amina A. Negash et al.
IMMUNOLOGICAL REVIEWS (2015)
Initiation and perpetuation of NLRP3 inflammasome activation and assembly
Eric I. Elliott et al.
IMMUNOLOGICAL REVIEWS (2015)
Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1
Joo-Hung Park et al.
IMMUNOLOGY LETTERS (2015)
Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice
Arvin Iracheta-Vellve et al.
JOURNAL OF HEPATOLOGY (2015)
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
Kele Cui et al.
JOURNAL OF HEPATOLOGY (2015)
Single-cell imaging of inflammatory caspase dimerization reveals differential recruitment to inflammasomes
M. G. Sanders et al.
CELL DEATH & DISEASE (2015)
Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease
Cosmin S. Voican et al.
LIVER INTERNATIONAL (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki et al.
JOURNAL OF INFLAMMATION RESEARCH (2015)
Mechanism of NLRP3 inflammasome activation
Fayyaz S. Sutterwala et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice
Sarita Olteanu et al.
DIGESTIVE AND LIVER DISEASE (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation
Hiroe Honda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis
Timea Csak et al.
LIVER INTERNATIONAL (2014)
Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Soo Jin Yang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells
Wei Chen et al.
PLOS ONE (2014)
IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation
Keng-Mean Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Inflammasomes
Marcel R. de Zoete et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Regulation of interleukin 1α secretion by inflammasomes
Amir S. Yazdi et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
Daryl T. -Y. Lau et al.
GASTROENTEROLOGY (2013)
Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
Yue Zheng et al.
IMMUNITY (2013)
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
Stefan Freigang et al.
NATURE IMMUNOLOGY (2013)
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Elisa Benetti et al.
MEDIATORS OF INFLAMMATION (2013)
Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice
David A. DeSantis et al.
MEDIATORS OF INFLAMMATION (2013)
IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
Amina A. Negash et al.
PLOS PATHOGENS (2013)
Interactions between Nod-like receptors and intestinal bacteria
Marcel R. de Zoete et al.
FRONTIERS IN IMMUNOLOGY (2013)
An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology
Rojo A. Ratsimandresy et al.
FRONTIERS IN IMMUNOLOGY (2013)
Sterile Inflammation in the Liver
Paul Kubes et al.
GASTROENTEROLOGY (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1
Olaf Gross et al.
IMMUNITY (2012)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
被撤回的出版物: Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex (Publication with Expression of Concern. See vol. 100, pg. 1342, 2019) (Retracted article. See vol. 100, pg. 1714, 2019)
Dylan Burdette et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Inflammasomes in liver diseases
Gyongyi Szabo et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease
Sorina Georgiana Boaru et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Laura J. Dixon et al.
LABORATORY INVESTIGATION (2012)
Inflammasomes in health and disease
Till Strowig et al.
NATURE (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Sensing and reacting to microbes through the inflammasomes
Luigi Franchi et al.
NATURE IMMUNOLOGY (2012)
IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection
Hilario J. Ramos et al.
PLOS PATHOGENS (2012)
Immunomodulatory functions of type I interferons
Jose M. Gonzalez-Navajas et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and-8 expression on peripheral CD4+and CD8+T-cells
J. E. Arends et al.
APOPTOSIS (2011)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Greta Guarda et al.
IMMUNITY (2011)
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
Yehuda Kamari et al.
JOURNAL OF HEPATOLOGY (2011)
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C
M. L. Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Alcoholic Liver Disease
Robert S. O'Shea et al.
HEPATOLOGY (2010)
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Mechanism of NLRP3 Inflammasome Activation
Chengcheng Jin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2010)
Intracellular DNA recognition
Veit Hornung et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Inflammasome-mediated regulation of hepatic stellate cells
Azuma Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Cellular and molecular biology of HCV infection and hepatitis
Hengli Tang et al.
CLINICAL SCIENCE (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Signalling pathways in alcohol-induced liver inflammation
Pranoti Mandrekar et al.
JOURNAL OF HEPATOLOGY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C
Paul J. Pockros et al.
HEPATOLOGY (2007)
Histological response to interferon alfa-based therapies in hepatitis C
SS Lee
SEMINARS IN LIVER DISEASE (2004)
Course and outcome of hepatitis C
JH Hoofnagle
HEPATOLOGY (2002)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
分享论文
